Pfizer to offload about 6% stake in Sensodyne-maker Haleon, says bookrunner
Pfizer intends to sell about 540 million shares in British consumer healthcare company Haleon, a bookrunner said on Monday, ...
Pfizer Set to Raise £2.7 Billion From Haleon Stake Sale
Pfizer Inc. plans to sell 540 million worth of shares in Haleon Plc, as it pares back its holding in the UK consumer health ...
ENDPOINTS NEWS8h
Pfiz­er to fur­ther de­crease stake in con­sumer health com­pa­ny Ha­le­on
Pfizer will continue shrinking its ownership in the British consumer health company Haleon, according to an announcement ...
World Street | Powell hints at smaller cuts ahead, Aston Martin's profit warning, PepsiCo's new venture and more
From US drugmaker Pfizer's stake sale in Sensodyne maker Haleon to Beijing joining the list of Chinese cities easing ...
GlobalCapital8h
Fireworks in ECM with Haleon block and NBG privatisation
Goldman Sachs, JP Morgan, Morgan Stanley and UBS are global coordinators on the trade, with Barclays, Bank of America, BNP ...
devdiscourse5h
Breaking Health News: Bird Flu Outbreak, Drug Lawsuits, and Abortion Rights
This summary covers several health-related news, including Germany's bird flu outbreak, Bristol Myers' lawsuit victory, ...
Pfizer to sell about $3.25 billion stake in Sensodyne-maker Haleon, bookrunner says
Pfizer's stake sale in British consumer healthcare company Haleon has been upsized by 100 million shares to 640 million ...
Pfizer Intends to Sell Approx 540 Million Ordinary Shares in Haleon
Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms around the world to identify trading and investing ...
Pfizer to Pare Haleon Stake With 540 Million Share Offering
Pfizer Inc. announced a further reduction of its stake in Haleon Plc, offering to sell about a 5.9% stake in the UK consumer ...